# Application of TAVI at Experienced Interventional Cardiac Centers Without On-site Cardiac Surgery (ATLAS Study)

Study · id `cardio:ct-nct06818006` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06818006](<https://clinicaltrials.gov/study/NCT06818006>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06818006

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 600 participants.

## Technical summary

Registry record NCT06818006. Randomized; single masking; primary purpose treatment. Start 2026-12-01 (anticipated); primary completion 2030-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 600 participants (planned count; ClinicalTrials.gov record NCT06818006, source copy `cardio:ctgov-nct06818006-2026-10-27`, retrieved 2026-10-31)
- Planned start: 2026-12-01 (anticipated) (ClinicalTrials.gov record NCT06818006, source copy `cardio:ctgov-nct06818006-2026-10-27`, retrieved 2026-10-31)
- Primary completion: 2030-12 (anticipated) (ClinicalTrials.gov record NCT06818006, source copy `cardio:ctgov-nct06818006-2026-10-27`, retrieved 2026-10-31)
- Completion: 2030-12 (anticipated) (ClinicalTrials.gov record NCT06818006, source copy `cardio:ctgov-nct06818006-2026-10-27`, retrieved 2026-10-31)
- Countries: Canada (ClinicalTrials.gov record NCT06818006, source copy `cardio:ctgov-nct06818006-2026-10-27`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06818006-2026-10-27`, retrieved 2026-10-31)

## The registry's words

- Brief title: Application of TAVI at Experienced Interventional Cardiac Centers Without On-site Cardiac Surgery (ATLAS Study)
- Acronym: ATLAS
- Condition: Aortic Stenosis
- Condition: Severe Aortic Stenosis
- Intervention (Procedure): Transcatheter Aortic Valve Replacement (TAVR) with surgical oversight
- Intervention (Procedure): Transcatheter Aortic Valve Replacement (TAVR) without surgical oversight
- Lead sponsor: University of Alberta
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: University of Alberta (`cardio:org-university-of-alberta`)

## Provenance

Content hash: 0a3f22b333aa8d855a55a0192575cd3d216eed0a42c49d5dea448c8135d2facf
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
